PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 189 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,864,000 | -38.4% | 842,478 | +34.6% | 0.01% | -44.4% |
| Q3 2016 | $41,975,000 | +134.0% | 626,024 | +4.0% | 0.01% | +125.0% |
| Q2 2016 | $17,936,000 | +164.5% | 602,071 | +160.7% | 0.00% | +100.0% |
| Q1 2016 | $6,782,000 | -64.3% | 230,920 | -4.7% | 0.00% | -50.0% |
| Q4 2015 | $19,006,000 | +10.9% | 242,424 | +6.6% | 0.00% | 0.0% |
| Q3 2015 | $17,133,000 | -35.9% | 227,353 | -0.7% | 0.00% | -33.3% |
| Q2 2015 | $26,741,000 | -82.6% | 229,042 | -64.8% | 0.01% | -83.8% |
| Q1 2015 | $153,457,000 | +34.4% | 649,940 | +7.8% | 0.04% | +32.1% |
| Q4 2014 | $114,145,000 | -10.8% | 603,082 | +12.4% | 0.03% | -22.2% |
| Q3 2014 | $127,994,000 | +266.4% | 536,506 | +1.4% | 0.04% | +260.0% |
| Q2 2014 | $34,935,000 | -42.3% | 529,311 | -9.0% | 0.01% | -44.4% |
| Q1 2014 | $60,582,000 | +7.6% | 581,739 | +7.0% | 0.02% | +5.9% |
| Q4 2013 | $56,278,000 | +84.0% | 543,593 | -4.7% | 0.02% | +70.0% |
| Q3 2013 | $30,593,000 | +36.8% | 570,135 | +13.1% | 0.01% | +25.0% |
| Q2 2013 | $22,367,000 | – | 504,098 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |